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Centenarians are the paradigm of human extreme longevity and healthy aging, because 
they have postponed, if not avoided, mayor age-related diseases. The purpose of this 
study was to investigate potential differences in resting heart rate variability (HRV) between 
young adults, octogenarians, and centenarians and assess whether HRV variables are 
predictors of all-cause mortality in centenarians. To this end, three groups of participants: 
young adults (N = 20; 20.6 ± 2.3 years), octogenarians (N = 18; 84.1 ± 2.6 years), and 
centenarians (N = 17; 101.9 ± 1.9 years) were monitored for 15 min at rest (seated, without 
moving or talking) to measure RR intervals, from which HRV was evaluated. Our results 
showed a clear decrease with age in the main parasympathetic HRV variables, as well 
as in the standard deviation (SD) of the RR series [SD of normal-to-normal interval (SDNN)] 
and in low frequency (LF) heart rate (HR) oscillations, although differences between 
octogenarians and centenarians did not reach statistical significance. In 14 centenarians 
followed until death, only SDNN showed significant correlation (ρ = 0.536; p = 0.048) with 
survival prognosis. Additionally, SDNN <19 ms was associated with early mortality (≤1 year) 
in centenarians (Hazard Ratio = 5.72). In conclusion, HRV indices reflecting parasympathetic 
outflow as well as SDNN and LF all present an age-related reduction, which could 
be representative of a natural exhaustion of allostatic systems related to age. Moreover, 
low SDNN values (<19 ms) could be associated with early mortality in centenarians. HRV 
seems to play a role in exceptional longevity, which could be accounted for by centenarians’ 
exposome.
Keywords: electrocardiography, autonomic nervous system, parasympathetic nervous system, heart rate, 
heart rate variability, mortality, centenarians, aging
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INTRODUCTION
Heart rate variability (HRV) is defined as “the oscillation in 
the interval between consecutive heart beats” (Malik et al., 1996). 
HRV is the result of the interaction of multiple regulatory 
mechanisms that operate at different time scales, including 
long-term mechanisms like circadian rhythms, core body 
temperature, or metabolism and short-term mechanisms involving 
the autonomic, cardiovascular, and respiratory systems (Shaffer 
and Venner, 2013). Short-term spectral analysis of HRV usually 
reveals at least two frequency components, a low frequency 
(LF) component (0.04–0.15  Hz) and a high frequency (HF) 
component (>0.15  Hz; Malik et  al., 1996). These components 
have been widely used to measure sympathetic and 
parasympathetic nervous systems, although their underlying 
physiological mechanisms are still unclear and a matter of 
debate (Billman, 2013).
In the last decades, several studies have reported that HRV 
decreases with age, suggesting an age-dependent decline in 
autonomic nervous system (ANS) activity in geriatric patients 
(Craft and Schwartz, 1995; Piccirillo et  al., 1995). The majority 
of these studies have been mainly performed in older adults up 
to 80–85  years old, whereas older adults over age 85 have not 
received much attention. Centenarians represent the survival tail 
of the population (with a lifespan at least 15–20  years longer 
than the average westerner) and a model of healthy aging 
(Christensen et al., 2008). Indeed, centenarians escaped the diseases 
of the pre-antibiotic era and have postponed/avoided aging-related 
diseases as well as their fatal consequences (Salvioli et  al., 2008).
The study of centenarians constitutes a fascinating research 
into the characteristics that allow individuals to attain an 
exceptionally long lifespan. Few works have studied HRV in 
centenarians. Piccirillo et  al. (1998) and Paolisso et  al. (1999) 
found that centenarians present higher power in HF heart 
rate (HR) oscillations and lower power in LF than old adults 
(75–100  years old in Paolisso et  al. and 81–100  years old in 
Piccirillo et  al.), suggesting age-related increase in 
parasympathetic activity and reduction in sympathetic activity. 
These results are in line with those obtained by Zulfiqar (2010) 
who enrolled subjects up to 99  years old and demonstrated 
that parasympathetic time-domain HRV measures decrease with 
age, reaching a nadir in the 7th–8th decade. From the 8th 
decade, these HRV measures are shown to rise, with the authors 
proposing this reversal of the decrease in parasympathetic 
function as a key determinant of longevity. In contrast, another 
study conducted in centenarians linked HRV with mortality 
during 4-year follow-up, showing that among all frequency-
domain variables only higher LF/HF ratio was associated with 
survival (Shimizu et  al., 2002).
Eight out of 10 centenarians are women (Teixeira et al., 2017). 
In 2016, Koenig and Thayer (2016) published a meta-analysis 
with 63,612 participants (31,970 females), revealing that: although 
adult women showed greater mean HR (MHR) than adult 
male, the female heart is characterized by a dominance of 
vagal activity (greater HF) and lower standard deviation (SD) 
of normal-to-normal intervals (SDNN). However, these sex 
differences may disappear in older adults (Voss et  al., 2015; 
Koenig and Thayer, 2016), as a consequence of a variety of 
age-related changes such as: endocrine, brain structure, brain 
perfusion, or behavioral differences.
Due to the lack of current evidence and the discrepancies 
in the reported outcomes, the present study aimed at investigating 
potential differences in women’s HRV between young adults, 
octogenarians, and centenarians and assess whether HRV 
variables can predict all-cause mortality in centenarians followed 
up until the time of death.
MATERIALS AND METHODS
Participants
Women aged 18–26  years in the group of young adults, 
80–90  years in the group of octogenarians, and ≥100  years 
in the case of centenarians were included in the study. Due 
to the low number of centenarians, four men were additionally 
included in this group. In total, the young adults, octogenarians, 
and centenarians groups contained 20, 18, and 17 subjects, 
respectively. Exclusion criteria included the following: subjects 
going through an acute disease, suffering from heart diseases 
(e.g., heart failure or atrial fibrillation), or being on cardiac 
medication. Subjects who had a stroke or were suffering from 
chronic diseases such as diabetes, hypertension, chronic 
obstructive pulmonary disease, osteoarthritis, dementia, 
Parkinson’s, or thyroid diseases were included in the study 
because of their high prevalence in the last decades of life. 
The study was approved by the Clinical Research Ethics 
Committee of the University Hospital of Alcorcón (ID of the 
approval: 16/50) and was conducted adhering to the Declaration 
of Helsinki. After a clear explanation of the potential risks of 
the study, all volunteers (or their legally responsible for older 
adults with cognitive problems) provided written informed 
consent to participate in the study.
Experimental Design
All the subjects completed one test session. Prior to the test 
session, subjects were asked to adhere to the following 
instructions: (1) avoid exercise or strenuous physical activity 
the day before the test; (2) drink plenty of fluids over the 
24  h period preceding the test; (3) get an adequate amount 
of sleep (6–8  h) the night before the test; (4) avoid substances 
such as tobacco, alcohol, or stimulants (caffeine, theine, taurine, 
etc.) in the 8  h before the test; (5) avoid food for 3  h prior 
to taking the test; and (6) wear comfortable, loose-fitting 
clothing. All the subjects were tested in an environmentally 
controlled room (22–23°C) between 9:00 and 13:00  h. They 
were monitored for 15 min at rest (seated, without any movement 
or talking) to measure RR intervals. RR intervals were recorded 
on a beat-to-beat basis by using an HR monitor (RS800, Polar 
Electro Oy, Kempele, Finland) with a sampling frequency of 
1,000  Hz, thus providing an accuracy of 1  ms for each RR 
period. This device has been recently validated, showing to 
provide comparable performance with respect to the 
electrocardiogram when analyzing HRV at rest (de Rezende 
Barbosa et  al., 2016; Hernando et  al., 2016).
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HRV Variables
HRV variables have commonly used to assess sympathetic and 
parasympathetic nervous systems. The LF component of HRV 
is assumed to provide information on cardiac sympathetic and 
parasympathetic neural activity, together with other regulatory 
mechanisms and baroreflex (Eckberg, 1997). The HF component, 
on the other hand, is assumed to be vagally mediated and driven 
by respiration, measuring the so-called respiratory sinus arrhythmia 
(RSA; Berntson et  al., 1993). Based on these assumptions, the 
ratio of LF to HF (LF/HF) has been proposed to quantify the 
relationship between sympathetic and parasympathetic activities 
(i.e., the sympatho-vagal balance; Malik et  al., 1996).
However, although these spectral indices are well-standardized, 
their physiological interpretation has been criticized. This especially 
applies to the relationship between LF power and cardiac sympathetic 
regulation (Eckberg, 1997; Billman, 2013; Reyes del Paso et al., 2013), 
with LF power decreasing during situations expected to increase 
sympathetic activity, such as exercise or myocardial ischemia, and 
lack of correlation between direct recording of sympathetic nerve 
activity and LF power in either healthy subjects or patients with 
heart failure. The interpretation of HF power has been also 
challenged, especially when the respiratory rate does not fall within 
the HF band (0.15–0.4  Hz; Laborde et  al., 2017). Different 
approaches have been proposed to overcome this limitation by 
redefining the HF band (Bailón et  al., 2007; Varon et  al., 2018). 
It has also been suggested that sympathetic neural activity may 
modulate the HF component (Billman, 2013). Therefore, the 
physiological interpretation of the LF/HF ratio is unclear and 
likely underestimates the complex interactions between the 
sympathetic and parasympathetic regulation of HR (Billman, 2013).
Normalized LF power (LFn) represents the proportional 
contribution of sympathetic modulation (Malik et  al., 1996), in 
the same way and with the same limitations as LF/HF ratio 
represents sympatho-vagal balance. A mathematical relationship 
exists between LFn and LF/HF ratio: LFn = (1 + (LF/HF) − 1) − 1, 
so individual LFn values contain no more information than individual 
LF/HF ratio values (Heathers, 2014). However, statistical results 
on them might differ due to the volatility of the LF/HF ratio 
when HF power approaches zero (Billman, 2013; Heathers, 2014).
Regarding time-domain variables, SDNN reflects all the 
cyclic components responsible for HRV (Laborde et al., 2017). 
Lastly, the root mean square of successive differences (RMSSD), 
the percentage of RR intervals which exceed 50  ms from 
the previous one (pNN50), and the SD of successive differences 
(SDSD) are correlated with the HF band, so vagal activity 
is considered to be  in the physiological origin of these 
three variables. Of these, RMSSD is normally preferred since 
it is less influenced by respiration (Laborde et  al., 2017). 
Despite the former caveats in their interpretation, the study 
of HRV indices is an area of great interest as they provide 
a low-cost and non-invasive window into ANS regulation 
of the heart.
Data Acquisition and Processing
HRV analysis was performed on 3-min running windows taken 
every 30 s. In each window, outlier RR intervals were identified 
by imposing a limit on the derivative of the instantaneous 
HR, which cannot exceed a time-varying threshold based on 
the median of its previous values (Mateo and Laguna, 2003). 
Only those windows with less than 10 outliers (always below 
5% in this study) were considered for further analysis. Two 
different HRV representations were used for time and frequency 
domain HRV indices estimation.
For time domain indices, the RR series was used, after 
correction of identified outlier RR values using the interpolation 
proposed in Mateo and Laguna (2003). The following indices 
were computed: MHR, RMSSD, pNN50, SDSD, and SDNN 
(Malik et  al., 1996).
For frequency domain indices, the HRV representation used 
is the modulating signal, based on the heart timing signal, 
since it was shown to outperform other HRV representations 
for frequency domain indices estimation (Mateo and 
Laguna, 2000). The modulating signal, assumed to carry 
information from the ANS, was estimated from the beat occurrence 
time series, derived from the recorded RR intervals, based on 
the time-varying integral pulse frequency modulation model 
(Bailón et  al., 2011). First, the instantaneous HR signal was 
estimated, sampled at a sampling frequency Fs  =  4  Hz, and 
denoted by dHR(n). Subsequently, the time-varying MHR signal, 
dMHR(n), was estimated by low-pass filtering dHR(n) with a cutoff 
frequency of 0.03 Hz. The modulating signal, m(n), was estimated 
by normalizing the HRV signal, dHRV(n)  =  dHR(n)  −  dMHR(n), 
by the time-varying MHR, i.e., m(n)  =  dHRV(n)/dMHR(n). Note 
that the modulating signal m(n) is adimensional. The purpose 
of this normalization is to alleviate the effect that changes in 
MHR have on HRV (Bailón et  al., 2011). Then, the power 
spectral density (PSD) of the modulating signal m(n) was 
estimated using Welch periodogram with internal window of 
2  min and 50% overlap. The power in the following bands 
was estimated: (i) LF, from 0.04 to 0.15  Hz; (ii) HF, from 0.15 
to 0.40  Hz; (iii) extended HF (HFext), from 0.15 to half the 
MHR, to avoid misestimation of the HF component when 
respiratory rate is above 0.4  Hz (24  breaths per minute; Bailón 
et  al., 2007). The LFn power was computed by dividing LF 
power by the sum of LF and HF powers (LFn), and the extended 
LFn was determined by dividing LF by the sum of LF and 
HFext (LFn_ext). Finally, the ratio between the LF and HF 
powers (LF/HF) and the ratio between LF and HFext powers 
(LF/HFext) were calculated.
As HRV analysis was performed on running 3-min windows 
taken every 30 s, the mean of each HRV variable in all running 
windows with less than 10 outlier RR values was computed 
to characterize each subject.
Statistical Analysis
Descriptive values are presented as mean  ±  SD and HRV 
values are reported as median and (1st quartile–3rd quartile). 
The normality of data was checked with the Shapiro-Wilk 
test. Since the data distribution violated the assumption of 
normality required by parametric tests and could not 
be  corrected by common transformations, a non-parametric 
analysis was used. To assess differences between the three age 
groups, Kruskal-Wallis test (non-parametric equivalent of 
one-way ANOVA) with Bonferroni correction was performed. 
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The Dunn-Bonferroni post hoc method was used for pairwise 
comparisons. A multiple linear regression was performed to 
control for potential confounding effects like the body mass index 
(BMI). To evaluate the magnitude of the difference, effect size 
(ES) was calculated as: ES = chi2/(k − 1), where k = total number 
of subjects. The difference was considered as small when ES < 0.2, 
small to medium when ES  =  0.2–0.5, medium to large when 
ES  =  0.5–0.8, and large when ES  >  0.8 (Cohen, 1992).
A sub-analysis was carried out by following centenarians 
until their death and calculating Spearman’s correlation 
coefficient (ρ) between HRV variables and “time to death.” 
For the HRV variables showing significant correlation to 
“time to death,” centenarians were divided into two groups 
by setting a cut point that defined a high risk group 
containing one third of the centenarian population and a 
low risk  group containing the remaining two thirds. The 
Mann-Whitney U test was used to compare differences 
between the statistical distributions of the two groups. 
Kaplan-Meier survival analysis was performed and the 
log-rank test was used to test survival differences between 
the two groups. Additionally, the value of HRV variables 
in predicting survival was determined by Cox proportional 
hazards analyses. Statistical analyses were performed using 
IBM SPSS (version 25; Chicago, IL, United  States). The 
significance level was set at p  <  0.05.
RESULTS
Table  1 shows the descriptive characteristics of the groups.
An illustrative example of the RR interval series for each 
group is shown in Figure  1. Results obtained for the HRV 
variables in each age group are shown in Table  2. Differences 
between groups were only observed when analyzing the 
parasympathetic variables: RMSSD, pNN50, HF, HFext, and 
SDSD as well as LF and SDNN. All these variables decreased 
significantly with age (main effect: p < 0.05) but no statistically 
significant differences were found between octogenarians 
and centenarians.
We were able to follow up  14 centenarians until death. The 
three subjects with incomplete data were females but no 
significant differences with the 14 subjects included in the 
sub-analysis were found either in the descriptive variables or 
in the HRV variables. The only HRV variable that presented 
significant correlation with survival prognosis in centenarians 
(Table  3) was SDNN (ρ  =  0.536, p  =  0.048).
The 14 centenarians were divided according to the SDNN 
variable into two groups based on a cut point of 19  ms: 
Group  1 presenting low SDNN values (N  =  4; 15  ±  4  ms, 
range: 10–18) and Group  2 presenting high SDNN values 
(N  =  10; 49  ±  25  ms, range: 27–110). The difference between 
the statistical distributions of the two groups was statistically 
significant. Group  2 was associated with greater survival 
(1.6 ± 0.9 years, range: 0.3–3.5) than Group 1 (0.6 ± 0.3 years, 
range: 0.3–1.0) in Kaplan-Meier analysis (Log-rank test = 0.010, 
Figure  2). Mortality risk in Group  1 was five times higher 
(p  =  0.028; Hazard Ratio  =  5.72) than in Group  2. 
No relation was found between subjects’ age at RR recording 
time and time to death (p  =  0.477).
DISCUSSION
The present study shows that parasympathetic time-domain 
HRV measures as well as SDNN and LF all decrease with 
age; moreover, other variables such as LFn or LF/HF ratio 
do not indicate differences between age groups. In relation 
to survival prognosis, SDNN was the only HRV measure 
showing moderate correlation (ρ  =  0.5–0.7) with time to 
death in centenarians, with SDNN values below 19  ms being 
associated with early mortality (≤1  year) in centenarians 
(Hazard Ratio  =  5.72).













Women (%) 100 100 76.5













Total number 3.3 ± 1.7 (0–5) 3.3 ± 1.0 (2–6)
*All young adults were healthy.
Scale values are mean ± standard deviation (SD) and min-max; BMI, body mass index; 
CVD, cardiovascular disease; AHT, arterial hypertension; COPD, chronic obstructive 
pulmonary disease.
FIGURE 1 | Example of the RR interval series for one subject from each age 
group.
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HRV Measures
When analyzing the main parasympathetic HRV variables 
(RMSSD, pNN50, HF, and SDSD; Malik et  al., 1996; Laborde 
et  al., 2017), a clear decrease with age is observed in all of 
them, with very remarkable differences between young adults 
and older adults but without significant differences between 
octogenarians and centenarians. This age-related decrease can 
be  appreciated in the illustrative examples of Figure  1 and 
has already been reported by other authors (Umetani et  al., 
1998; Bonnemeier et  al., 2003; Abhishekh et  al., 2013). Also, 
to the best of our knowledge, this is the first time that it has 
been described in centenarians. It should be  emphasized that 
our results differ from those of Paolisso et  al., Zulfiqar et  al., 
and Almeida-Santos et al. since they establish a parasympathetic 
nadir at 75–80, 70–79, and 60–69  years, respectively, and our 
study indicates that parasympathetic HRV variables continue 
to decrease in centenarians (Piccirillo et  al., 1998; Zulfiqar 
et  al., 2010; Almeida-Santos et  al., 2016). There are several 
possible explanations for our sample of centenarians not showing 
a reversal of the decrease in parasympathetic function. First, 
erratic rhythms may have a confounding effect on age-related 
changes in parasympathetic HRV indices (Nicolini et al., 2012), 
which is why our study only analyzes RR segments free of 
erratic patterns, allowing the presence of no more than 10 
outlier values in each 3-min window of analysis. Second, 
although the BMI of the octogenarian sample was significantly 
higher, BMI had no effect as a confounding variable (p > 0.05 in 
the multiple linear regression). Some studies have found reduced 
HRV in underweight and overweight adult women (Triggiani 
et  al., 2017; Gerardo et  al., 2019), but studies in the literature 
investigating the oldest old are scarce. The lower BMI in the 
centenarian sample could be  an indicator of healthy body 
composition but also a simple consequence of age-associated 
sarcopenia or osteoporosis. On the other hand, previous studies 
in centenarians have been very restrictive in the selection of 
subjects, including only very healthy and independent subjects 
(Piccirillo et  al., 1998; Paolisso et  al., 1999; Zulfiqar et  al., 
2010), which may involve a selection bias (Tan et  al., 2019). 
The parasympathetic decrease in centenarians found in our 
study could, thus, be more representative of a natural exhaustion 
of allostatic systems related to age.
As already mentioned, the interpretation of the standard 
HF band (0.15–0.4  Hz) is compromised when respiratory rate 
does not fall within this band (9–24  bpm). Since breathing 
was not monitored, power in the extended HF band (0.15-half 
MHR) was computed to account for respiratory rates that 








Median (Q1–Q3) Median (Q1–Q3) Median (Q1–Q3) p ES
LF 0.0015 (0.0012–0.0031)†‡ 0.0004 (0.0001–0.0017) 0.0002 (0.0001–0.0004) <0.001* 0.441
LFn 0.5708 (0.5204–0.6266) 0.6131 (0.4608–0.7031) 0.5366 (0.3867–0.6456) 0.504 0.025
LFn_ext 0.5517 (0.4969–0.5997) 0.5701 (0.4286–0.6202) 0.4426 (0.2840–0.5887) 0.168 0.066
HF 0.0016 (0.0007–0.0032)†‡ 0.0002 (0.0000–0.0009) 0.0001 (0.0001–0.0003) <0.001* 0.414
HFext 0.0018 (0.0008–0.0035)†‡ 0.0002 (0.0001–0.0010) 0.0002 (0.0001–0.0005) <0.001* 0.367
RMSSD 57.97 (41.83–109.35)†‡ 24.37 (10.14–67.29) 36.37 (18.71–50.55) 0.005* 0.194
pNN50 24.31 (12.61–41.24)†‡ 2.62 (0.26–22.00) 6.88 (0.85–9.29) <0.001* 0.283
SDSD 58.02 (41.91–109.59)†‡ 24.41 (10.16–67.44) 36.44 (18.74–50.57) 0.005* 0.194
SDNN 68.13 (52.55–130.75)†‡ 41.38 (17.41–82.03) 36.77 (21.25–45.90) 0.001* 0.276
LF/HF 1.44 (1.12–1.91) 1.78 (0.91–2.39) 1.36 (0.68–2.19) 0.650 0.016
LF/HFext 1.32 (1.03–1.61) 1.41 (0.80–1.75) 0.85 (0.43–1.60) 0.303 0.044




Values are expressed as median and (1st quartile–3rd quartile). LF, low frequency; LFn, normalized LF; LFn_ext, extended LFn; HF, high frequency; HFext, extended HF; RMSSD, 
root mean square of successive differences; pNN50, percentage of RR intervals which exceed 50 ms from the previous one; SDSD, SD of successive differences; SDNN, SD of the 
RR series; LF/HF, ratio between LF and HF; LF/HFext, ratio between LF and HFext; MHR, mean heart rate; p, p-value for Kruskal-Wallis test; ES, effect size.
TABLE 3 | Survival prognosis in centenarians (N = 14).
LF LFn LFn_ext HF HFext RMSSD pNN50 SDSD SDNN LF/HF LF/HFext MHR
ρ 0.423 0.172 0.295 0.190 0.232 0.304 0.247 0.304 0.536 0.214 0.251 −0.082
p 0.131 0.557 0.305 0.516 0.426 0.290 0.395 0.290 0.048* 0.463 0.386 0.782
*p < 0.05. LF, low frequency; LFn, normalized LF; LFn_ext, extended LFn; HF, high frequency; HFext, extended HF; RMSSD, root mean square of successive differences; pNN50, 
percentage of RR intervals which exceed 50 ms from the previous one; SDSD, SD of successive differences; SDNN, SD of the RR series; LF/HF, ratio between LF and HF; LF/HFext, 
ratio between LF and HFext; MHR, mean heart rate; ρ, Spearman’s correlation coefficient with “time to death”; p, p-value for Pearson’s correlation coefficient.
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might exceed 24  bpm, as suggested in Bailón et  al., 2007. As 
it can be  seen in Table  2, results of the standard HF band 
were parallel to those of the extended HF band, suggesting 
that in this database, respiratory rates were in the standard 
HF band (0.15–0.40  Hz). Therefore, HF could be  considered 
as a measure of the vagal tone (Laborde et  al., 2017).
SDNN can be considered as an indicator of global autonomic 
regulation, although it has been claimed that in short-term 
recordings, the primary source of its variations is 
parasympathetically-mediated RSA (Shaffer and Ginsberg, 2017). 
In agreement with previous studies (Zulfiqar et  al., 2010; 
Almeida-Santos et  al., 2016; Sammito and Böckelmann, 2016), 
SDNN values decline with age, further reflecting an 
age-dependent decline in ANS activity. LF results were in the 
same line as the parasympathetic HRV variables and SDNN, 
probably because the recording was made while sitting upright 
during resting and under these conditions the primary 
contributors to HRV have been suggested to be  related to 
parasympathetic and baroreflex activity rather than to sympathetic 
activity (Shaffer and Ginsberg, 2017).
Other HRV variables, LFn and LF/HF, whose physiological 
interpretation is usually controversial, have been additionally 
investigated in our study, neither of them showing statistically 
significant differences between groups.
HRV and Survival Prognosis in 
Centenarians
In recent decades, HRV has been confirmed as a strong, 
independent predictor of morbidity and all-cause mortality 
(Billman, 2011; Kemp et al., 2017). To investigate HRV variables 
that may be associated with survival prognosis in centenarians, 
we  followed up subjects until death. Only SDNN showed 
significant correlation (ρ  =  0.536, p  =  0.048) with survival 
prognosis in centenarians. The group of centenarians with low 
SDNN values presented five times greater mortality risk than 
centenarians with high SDNN values. In the framework of 
the research topic “Horizon 2030: Innovative Applications of 
Heart Rate Variability,” we  discuss about HRV and exceptional 
longevity. However these results should be read with perspective, 
as the sample of centenarians followed until death is 
heterogeneous in gender, including 4 men and 10 women.
Since Kleiger et  al. set the basis for the use of HRV in 
post-acute myocardial infarction risk stratification in 1987, 
SDNN is considered as a “gold standard” when recorded over 
a 24-h period. SDNN values below 50  ms are classified as 
unhealthy, 50–100 ms as compromised health, and above 100 ms 
as healthy (Kleiger et al., 1987). According to Bilchick et al. (2002), 
each 10-ms increase in SDNN confers a 20% decrease in risk 
of mortality. SDNN is the only variable presenting significant 
correlation with time to death in our cohort of centenarians. 
In particular, SDNN <19  ms turns out to be  indicative of 
early mortality (≤1  year). Of note, one subject presented a 
value of SDNN of 110  ms and was the one who lived the 
longest time (3.5  years) calculated from the time point when 
RR was recorded.
It should be noted that there are other RR-derived variables 
that have been related to increased mortality risk in the literature. 
The fact that they have not been found to be  associated with 
time to death in our study could be  due to the small sample 
of our cohort or to the particular characteristics of the studied 
centenarians. A classic example is high resting HR (Zhang 
et al., 2015). Additionally, a recent meta-analysis has established 
LF/HF ratio and SDNN as two of the variables with greater 
potential as predictors of mortality (Sen and McGill, 2018). 
Shimizu et  al. (2002) have also observed the relevance of LF/
HF ratio in a cohort of 27 centenarians. Finally, LF is one of 
the most controversial HRV indices in the literature. Some 
studies, such as the Framingham Heart Study, have associated 
a 1-SD decrement in LF with 1.70 times greater hazard for 
all-cause mortality (Tsuji et  al., 1994). On the other hand, 
cross-sectional studies in healthy centenarians have reported 
that high LF values are associated with increased mortality 
risk (Piccirillo et  al., 1998; Paolisso et  al., 1999).
Centenarians and the “Neurovisceral 
Integration Across a Continuum of Time” 
Framework
Centenarians are considered to be  a model of healthy and 
successful aging. It is well known that exceptional longevity 
is a partially inheritable phenotype that could be  explained 
in 20–35% by the genetic load (Rea et al., 2016). Consequently, 
it could be  that the ANS of the centenarians had a greater 
and innate adaptation level, and therefore they will take 20 years 
more than the general population to reach a level of depletion 
of the allostatic systems related to mortality. On the other 
hand, another feasible explanation would be  that centenarians 
FIGURE 2 | Kaplan-Meier curves depicting association between survival in 
centenarians (N = 14) and SDNN groups based on a cut point of 19 ms.
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have healthy behaviors that allow them to experience a less 
marked decrease in the function of the ANS. Non-genetic 
factors, including diet, physical activity, health habits, and 
psychosocial factors contribute approximately 50% of the 
variability in human lifespan (Rea et  al., 2016).
Recently, Kemp et  al. (2017) published a theoretical 
framework called “Neurovisceral Integration Across a 
Continuum of Time (NIACT)” where they propose that the 
function of the vagus nerve, indexed by resting-state HRV, 
plays a regulatory role on a variety of allostatic systems, 
therefore contributing to an increase or decrease in the risk 
of future morbidity and mortality. NIACT proposes that while 
age decreases vagal function, there are many interventions 
that may be  applied to contend such decreases including 
health behavior, meditation, and positive psychological 
interventions (Kemp et  al., 2017). Health behaviors related 
to improvements in HRV are similar to those that characterize 
the lifestyle of centenarians in different populations: regular 
physical activity, dietary habits, no drinking, and no smoking 
(Ozaki et  al., 2007; Kim et  al., 2012; Wu et  al., 2017). But 
psychological moments are also a key element in the NIACT 
framework, and in the same way, active engagement in 
community activities, high levels of self-perceived well-being, 
and satisfaction with life are defining elements of the centenarian 
population (Ozaki et  al., 2007; Kim et  al., 2012; Wu et  al., 
2017; Hitchcott et  al., 2018; Yorgason et  al., 2018). Therefore, 
the characteristic lifestyle of centenarians would imply a greater 
resilience, indexed by greater variability of the HR and, as 
described above, higher SDNN values would mean better 
survival prognosis in centenarians.
Strengths and Limitations
The main strength of the present study is the exceptionality 
of the sample, considering than being centenarian is a rare 
phenotype (17.3 centenarians per 100.000 inhabitants; Teixeira 
et  al., 2017). Secondly, centenarians were followed up to death 
and our study proposes SDNN <19  ms as a cutoff point to 
define a marker of early mortality (≤1 year), which is obtained 
from short-term measurements, thus more suitable for ambulatory 
care and patient monitoring. Given its ease of recording, short-
term variability allow measurements under homogeneous 
conditions, enabling the control of confounding factors and 
the reproducibility of the study (Li et  al., 2019). Moreover, 
RR measurements were acquired using a validated device and 
processed with methods that allow better identification of the 
erratic patterns.
On the other hand, one of the main limitations was gender 
heterogeneity in the centenarian group, with 76.5% of our 
centenarians being women. A meta-analysis has highlighted 
that women show greater vagal activity compared to men, 
noting the following possible etiological factors: estrogen, 
oxytocin, and neural control (Koenig and Thayer, 2016). Our 
sample, however, is very similar to the overall centenarian 
population in Europe (83.5% women; Teixeira et  al., 2017), 
and sex differences have been reported to disappear in the 
last age decades, especially in short-term HRV, presumably by 
the hormonal restructuring especially caused by the menopause 
in women (Bonnemeier et  al., 2003; Voss et  al., 2015; Koenig 
and Thayer, 2016). Indeed, when the statistical analysis of our 
study was performed by excluding men (N  =  4) from the 
sample of centenarians, results were similar to those reported 
in Table  2. Finally, recording conditions should be  taken into 
account before generalizing the results. For example, paced 
breathing was not considered in our work. Under resting 
conditions, the respiratory rate (9–24 bpm) is expected to be in 
the 0.15–0.40  Hz band (Shaffer and Ginsberg, 2017), but 
processing should account for the possibility that the respiratory 
rate goes outside this frequency band, as performed in the 
present work. A within-subject repeated measure design would 
have contributed to assess the reproducibility of our evaluations. 
In future research, more representative samples of centenarians 
would allow to confirm the results obtained by this study.
In conclusion, HRV indices reflecting parasympathetic outflow 
(RMSSD, pNN50, HF, and SDSD) as well as SDNN and LF 
all present an age-related reduction, which could be representative 
of a natural exhaustion of allostatic systems related to age. 
Moreover, low SDNN values (<19  ms) are indicative of early 
mortality (≤1  year) in centenarians. HRV seems to play a role 
in exceptional longevity, which could be  accounted for by 
centenarians’ exposome.
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